Literature DB >> 4968248

The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.

J E Drew, V F Marshall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4968248     DOI: 10.1016/s0022-5347(17)62782-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  9 in total

1.  The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

Authors:  W Dobrzecki; A Kaczmarek
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

Review 2.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.

Authors:  G Agnelli; M de Cunto; P Gresele; A del Favero
Journal:  Postgrad Med J       Date:  1982-06       Impact factor: 2.401

4.  Bladder hyperthermia in the treatment of vesical papillomatosis.

Authors:  G Lunglmayr; K Czech; F Zekert; G Kellner
Journal:  Int Urol Nephrol       Date:  1973-01       Impact factor: 2.370

5.  Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.

Authors:  T Niijima; K Koiso; H Akaza
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  In vitro and in vivo responses of a murine transitional cell carcinoma to doxorubicin, mitoxantrone and aclacinomycin-A.

Authors:  R J Ballou; M T Tseng
Journal:  Urol Res       Date:  1986

7.  Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.

Authors:  Fatemeh Fallah; Mahdi Fallah; Raheleh Sadat Sajadi Nia
Journal:  Curr Urol       Date:  2012-12-21

8.  On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT).

Authors:  P L Gutierrez; B E Cohen; G Sosnovsky; T A Davis; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 9.  Treatment of superficial bladder cancer.

Authors:  A Morales
Journal:  Can Med Assoc J       Date:  1980-05-24       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.